Colombia’s search for memory and cure for Alzheimer’s

0
8323
Dr. Francisco Lopera, leading researcher on early-onset Alzheimer's
Dr. Francisco Lopera, leading researcher on early-onset Alzheimer's

Each and every one of us at some point in our lives has faced memory loss. Fleeting, maybe. More worrisome as we grow older. It’s not about waking up in the morning and not knowing where you are, or the proverbial “Where have I placed my keys?” As a pathological deterioration of brain cells, Alzheimer’s erases your memory. You forget your name. You forget how to dress. You forget the faces and tender words of loved ones.

In central Antioquia, across small towns such as Angostura, La Carolina and Yarumal, Alzheimer’s disease strikes early. Many young men and women in their thirties show progressive signs of memory loss. Sometimes the early onset of the disease is combined with other neurological disorders such as Parkinson’s, epilepsy and schizophrenia. For many decades these individuals were shut off from society, hidden from public view and more tragically, thrown out on the street. For those who couldn’t explain sudden memory loss, they referred to it simply as “La Bobera”- the stupidity.

Dr. Francisco Lopera Restrepo, Professor and Head of the University of Antioquia’s Clinical Neurology Department has been in close contact with Alzheimer’s disease since he was a young man growing up in La Aurora, a small town near the epicenter of early-onset Alzheimer’s. Surrounded by close family and school friends who acquired the disease later on in life, Lopera became fascinated with how the brain works and decided to study Medicine with a specialization in Behavioral Neurology at his alma mater in 1970.

Dr. Francisco Lopera, leading researcher on early-onset Alzheimer's

Tracing the Paisa mutation through generations could help discover what causes early-onset Alzheimer’s in the general population.

The mysterious relationship between the brain and how the mind processes or loses memory is at the core of Dr.Lopera’s historic research. “The brain is the hardware, while the mind is our software,” explains Dr.Lopera as we meet at the laboratory of the Investigations Centre of the University (SIU) where all his research is conducted and housed.

Dr.Lopera’s investigations into early-onset Alzheimer’s date back to 1984 when he met his first family with the disease. Working towards his PhD he started looking into the genealogy of the family, realizing that the gene mutation went back generations. “It was hereditary and always began early,” recounts Dr.Lopera. As a first contact with a specific family-inherited disease, the researcher came across a similar case in the town of Yarumal. Here, a young man who sold lottery tickets had also lost his memory. So had his father and grandfather before him. Even some of the young man’s extended relatives.

A third case then turned up. This time it was a young woman from the town of Angostura in the central Andes. Although they all seemed to belong to different families spread across the mountainous Antioquia territory, Dr.Lopera began mapping the gene mutation of Alzheimer’s as it spread, devastating entire families and leaving few clues, and he was able to identify 25 different families with the exact same story.

Investigating birth certificates in parishes and going to public notaries, Dr.Lopera found that 14 of the 25 families came from the same genetic “trunk” and that this strand of Alzheimer’s moved from branch to twig relatively undetected. “I am convinced now that all 25 families are connected,” states Lopera.

The scientist has traced the gene back to the 1740s. Prior to this date, the gene could have originated in Spain or mutated locally. What is clear is that the gene has a “founding factor.” The Alzheimer’s gene known as the mutación paisa or Paisa mutation (Paisa being the name given to the inhabitants of Antioquia and its capital, Medellín) has three stages of development. First, is a pre-clinical phase when the gene strikes without the host knowing. There are no symptoms, no outward manifestations of memory loss. Then, a secondary stage when memory starts failing without cognitive breakdown. The third and final stage is brain atrophy or dementia.

“Before we only spoke of Alzheimer’s when the patient had dementia,” states Lopera. “Thanks to these families we have been able to clearly define the three stages.” For the family clans beset with early-onset Alzheimer’s, the first stage starts between the ages of 28 and 30. To reach this important medical marker, Dr.Lopera took 50 candidates to the Banner Alzheimer’s Institute in Phoenix, Arizona, to have PET scans of amyloid plaque build up. Amyloid-beta is a protein in the brain of patients with the disease.

From fifty volunteers, 20 were gene carriers, 20 were gene clean and 10 already showed early signs of clinical Alzheimer’s. None of the 40 pre-symptomatic candidates knew of their status with the disease or how it might develop. One medical fact was very evident: every person who carries the so-called “Paisa mutation” will inevitably get sick and develop Alzheimer’s.

After the first undetectable stage was deciphered, Dr.Lopera marked his second phase of cognitive impairment at age 44. Full dementia at age 49. Mapping the gene across 5,000 members of Antioquia as well as finding the “markers” for the developmental stages of the disease has catapulted Dr.Lopera to the top of medical research into Alzheimer’s. He has been extensively profiled in leading medical journals such as The Lancet and periodicals, such as the New York Times, and invited to join a global team of researchers who this year will begin work on a clinical trial that could eventually lead to a treatment and a drug called Crenezumab (created by Genentech) to stop the gene from developing into all out disease.

The Alzheimer’s trials in which Lopera’s early-onset Antioquia research is fundamental spanned an initial five years and cost USD $100 million. In as much as this investment represented a historic moment for medical research into one of the world’s most feared diseases, ongoing investigations could offer relief to millions around the world afflicted by conventional Alzheimer’s.

“If we find a cure against Alzheimer’s it could change many aspects of the mankind. Life expectancy could extend, as this disease is a premature aging process,” states Lopera. “If we are able to cure Alzheimer’s we will be probably be able to cure other degenerative neurological diseases as well.”

Although Lopera is enthusiastic of the medical advances with Alzheimer’s, he remains cautious that a cure is on the horizon. “This project is based on the amyloid hypothesis. At this moment, there is discussion if amyloid is really the cause of Alzheimer’s. I am convinced that the project will be successful independently of the medicine’s effectiveness because once and for all we would have tackled the amyloid debate.”

The virtue of Lopera’s studies lies in wanting to analyze the impact of drugs applied to amyloid in a healthy brain. This is a radical departure from the current research where drugs are given when a candidate already has an advanced state of disease. By the time the medication tries to connect, the brain cells are simply too destroyed. “We are going to do a preventive study with people who have minimal deposits of amyloid,” states Lopera. “Later on, we could do a pre-preventive study on persons younger than 28 who don’t have any amyloid, but are carriers.”

Dr. Francisco Lopera, leading researcher on early-onset Alzheimer's

Dr. Lopera’s research requires the intimate cooperation of families with genes that cause early-onset Alzheimer’s, including the donation of brains.

Of the 500 families around the globe with the gene for early-onset, 25 are in Antioquia. For this scientist the local population has provided the world with an ideal laboratory for the study of amyloid-rooted Alzheimer’s. Another defining aspect of the Antioquia illness is Dr.Lopera’s insistence on the role of geneology in tracking the gene. “We had situations in which persons who might never have met, who lived far removed, came together, and could recognize traits in each other.”

If potential sickness can bring people of all backgrounds together, then it has also torn millions apart. Alzheimer’s renders a subject lifeless, except that the body stays functional. Unlike certain cancers, persons with severe mental atrophy can live to an old age, and being unable to perform even the most basic of tasks, represent a high cost for governments and healthcare. The cost of Alzheimer’s is estimated at USD $600 billion every year. And this, not considering the difficult emotional and financial toll on families.

To get to the compound at the core of the Alzheimer’s debate, Lopera needed brains. Along with the dedicated team of his 30 medical students and interns, he has collected 200 human brains, which are carefully stored at the SIU. But getting his first donated brain required a good set of brakes.

The year was 1995. Alzheimer’s until then could only be conclusively diagnosed post mortem. Dr.Lopera devised a strategy to start a brain bank and went to the community. With a booth called “Neuro Banco” at the University of Antioquia’s Science Fair, flyers were passed out asking for brains. “We wanted brains from persons who had or knew of relatives with neurological disease,” remembers Dr.Lopera. People were curious but hardly responsive.

Then a woman in the town of Angostura passed away who had Alzheimer’s, and Dr.Lopera got in his car and drove to the wake. “I went to pray,” he remembers. “Between prayers and more prayers, I tried to convince her 14 children that this brain was important for science. I explained, one by one, that Alzheimer’s was in their family and that instead of letting the worms go at it, they could help others in fighting this disease.”

It seemed to work. They all agreed. An extended ‘Paisa’ family had reached a consensus. But then, at the eleventh hour, one son retracted asking for 20 Million Colombian pesos (USD $12,000). “You are going to sell my mother’s brain to the gringos!” was his belief. Stunned by this remark and the fact that Dr.Lopera would not pay for any brain, the children saw the value in his quest and authorized the brain’s removal.

Of the 200 brains in the SIU bank, 60 have hereditary early-onset Alzheimer’s. The donation program has been highly successful and has created awareness in Medellín and its surrounding towns, that the scientific research being done at the U of A needs the involvement of the community.

To lose your memory is to lose a sense of self. To lose this sense of self is to disconnect from your beliefs, your ideas, your emotions. A sickness which today affects 5.4 million in the U.S. alone has been growing steadily as baby boomers age. Even though conventional Alzheimer’s may be an inevitable sign of advanced aging, the Antioquia case study, and the many young men and women afflicted with early-onset, harbors the potential to transform modern medicine.

After three decades of research this soft spoken doctor takes it all in a day’s work. He is passionate about Medellín and that a cure for Alzheimer’s will be found. Although we may not be here to see it, there is one medical truth that will remembered: Dr.Lopera and the families of Antioquia have contributed to the health and memory of the world.

LEAVE A REPLY

Please enter your comment!
Please enter your name here